These rewired cells ultimately activate the same critical pathways (TCR and IL-2 pathways) as seen in native T cell responses but do so in a different temporal order and in response to different inputs allowing them to be far more effective as a tumor-targeted therapy (Fig 6). This evidence concerns the gene IL2 and neoplasm.